Quick Answer
SBC Medical Group Holdings Inc reported Diluted EPS of $0.50 per share for fiscal year 2025.
SBC Medical Group Holdings Inc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.50 | +4.2% |
| 2024 | $0.48 | +14.3% |
| 2023 | $0.42 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.12 | +300.0% | +500.0% |
| June 30, 2025 | $0.02 | -90.0% | -90.5% |
| March 31, 2025 | $0.21 | +5.0% | +600.0% |
| September 30, 2024 | $0.03 | -66.7% | -85.0% |
| June 30, 2024 | $0.20 | — | +0.0% |
| March 31, 2024 | $0.20 | — | +122.2% |
| September 30, 2023 | $0.09 | — | — |
- SBC Medical Group Holdings Inc showed an increase of +4.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, SBC Medical Group Holdings Inc’s diluted eps has grown by 19.0% (from $0.42 per share to $0.50 per share).
- The most recent figure is from SBC Medical Group Holdings Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: